Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 7/20 | 1.00 |
| ▸ | LMNA | P02545 | 7/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.72 |
| ▸ | SERPINA6 | P08185 | 5/20 | 0.72 |
| ▸ | TSHR | P16473 | 5/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.72 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.72 |
| ▸ | SNCA | P37840 | 4/20 | 0.72 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.72 |
| ▸ | PGR | P06401 | 4/20 | 0.72 |
| ▸ | MAPT | P10636 | 4/20 | 0.72 |
| ▸ | AR | P10275 | 3/20 | 0.72 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 0.72 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.72 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.72 |
| ▸ | CYP51A1 | Q16850 | 2/20 | 0.72 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1899376 | 1.00 | SHBG (1.00) | SHBGLMNAHSD17B10SERPINA6TSHR | |
| SCHEMBL4102864 | 1.00 | SHBG (1.00) | SHBGLMNAHSD17B10SERPINA6TSHR | |
| SCHEMBL1900826 | 1.00 | SHBG (1.00) | SHBGLMNAHSD17B10SERPINA6TSHR | |
| SCHEMBL13752654 | 1.00 | SHBG (1.00) | SHBGLMNAHSD17B10SERPINA6TSHR | |
| SCHEMBL4102861 | 1.00 | SHBG (1.00) | SHBGLMNAHSD17B10SERPINA6TSHR | |
| SCHEMBL10079003 | 0.89 | SHBG (0.80) | SHBGLMNAHSD17B10SERPINA6TSHR | |
| SCHEMBL18075707 | 0.89 | SHBG (0.80) | SHBGLMNAHSD17B10SERPINA6TSHR | |
| SCHEMBL572119 | 0.87 | SHBG (0.77) | SHBGLMNAHSD17B10SERPINA6TSHR | |
| SCHEMBL18799945 | 0.87 | SHBG (0.77) | SHBGLMNAHSD17B10SERPINA6TSHR | |
| SCHEMBL11209693 | 0.87 | SHBG (0.77) | SHBGLMNAHSD17B10SERPINA6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100197514-A1 | PROTEIN CRYSTAL OF HUMAN CYTOCHROME P450 AROMATASE AND USES THEREOF | HAUPTMAN-WOODWARD MEDICAL RESEARCH INSTITUTE, INC. (US) | 2010-08-05 | — | — | US | claimed |
| US-7687252-B2 | Protein crystal of human cytochrome P450 aromatase and uses thereof | Hauptman-Woodward Medcial Research Institute, Inc. (US) | 2010-03-30 | — | — | US | claimed |
| US-20090204378-A1 | PROTEIN CRYSTAL OF HUMAN CYTOCHROME P450 AROMATASE AND USES THEREOF | HAUPTMAN-WOODWARD MEDICAL RESEARCH INSTITUTE, INC. (US) | 2009-08-13 | — | — | US | claimed |
| WO-2009061859-A2 | PROTEIN CRYSTAL OF HUMAN CYTOCHROME P450 AROMATASE AND USES THEREOF | HAUPTMAN-WOODWARD MEDICAL RESEARCH INSTITUTE, INC. (US) | 2009-05-14 | — | — | WO | claimed |
| CN-122081260-A | Nonspecific peroxidase CsaUPO, coding gene thereof, recombinant microorganism, steroid epoxidation method and application | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4608876-A2 | ENDOCYTIC AGENTS | BioVentures, LLC (US) | 2025-09-03 | — | — | EP | disclosed |
| US-20240165032-A1 | DRUG DELIVERY SYSTEM | EB IP HYBRITABS B V (NL) | 2024-05-23 | — | — | US | disclosed |
| WO-2024092274-A2 | ENDOCYTIC AGENTS | BIOVENTURES, LLC (US) | 2024-05-02 | — | — | WO | disclosed |
| CN-113980883-B | Recombinant escherichia coli for high-yield hydroxylation steroid bulk drug and application thereof | 浙江理工大学 | 2023-11-07 | — | — | CN | disclosed |
| CN-113980883-A | Recombinant escherichia coli for high-yield hydroxylated steroid bulk drug and application thereof | 浙江理工大学 | 2022-01-28 | — | — | CN | disclosed |
| US-11130890-B2 | Adhesive composition, adhesive sheet, and method for producing same | TOYO INK SC HOLDINGS CO., LTD. (JP) | 2021-09-28 | — | — | US | disclosed |
| US-20210290551-A1 | DRUG DELIVERY SYSTEM | EB IP HYBRITABS B.V. (NL) | 2021-09-23 | — | — | US | disclosed |
| US-7687252-B2 | Protein crystal of human cytochrome P450 aromatase and uses thereof | Hauptman-Woodward Medcial Research Institute, Inc. (US) | 2010-03-30 | — | — | US | disclosed |
| EP-1551415-B1 | ORAL PHARMACEUTICAL COMPOSITION COMPRISING 15-HYDROXYTESTOSTERONE AND ITS ANALOGUES | PANTARHEI BIOSCIENCE BV (NL) | 2009-12-23 | — | — | EP | disclosed |
| US-20090204378-A1 | PROTEIN CRYSTAL OF HUMAN CYTOCHROME P450 AROMATASE AND USES THEREOF | HAUPTMAN-WOODWARD MEDICAL RESEARCH INSTITUTE, INC. (US) | 2009-08-13 | — | — | US | disclosed |
| WO-2009061859-A2 | PROTEIN CRYSTAL OF HUMAN CYTOCHROME P450 AROMATASE AND USES THEREOF | HAUPTMAN-WOODWARD MEDICAL RESEARCH INSTITUTE, INC. (US) | 2009-05-14 | — | — | WO | disclosed |
| US-20060122158-A1 | Pharmaceutical application of 15- or 16-substituted testosterone analogues | WILMINGTON TRUST | 2006-06-08 | — | — | US | disclosed |
| US-20060122158-A1 | Pharmaceutical application of 15- or 16-substituted testosterone analogues | WILMINGTON TRUST | 2006-06-08 | — | — | US | disclosed |
| EP-1551415-A1 | PHARMACEUTICAL APPLICATION OF 15- OR 16- SUBSTITUTED TESTOSTERONE ANALOGUES | Pantarhei Bioscience B.V. (NL) | 2005-07-13 | — | — | EP | disclosed |
| WO-2004022065-A1 | PHARMACEUTICAL APPLICATION OF 15- OR 16- SUBSTITUTED TESTOSTERONE ANALOGUES | PANTARHEI BIOSCIENCE B.V. (NL) | 2004-03-18 | — | — | WO | disclosed |